Literature DB >> 16815394

Mortality and serum urea and electrolytes on admission for hip fracture patients.

J R Lewis1, S K Z Hassan, R T Wenn, C G Moran.   

Abstract

OBJECTIVE: To assess the relationship between pre-operative serum urea and electrolyte concentrations and mortality in patients with hip fractures requiring surgery.
METHODS: A prospective observational study of 2963 consecutive patients admitted to a single trauma unit with a hip fracture, treated operatively.
RESULTS: The 30-day mortality for patients with low and normal urea concentrations was 6.9%. The 30-day mortality for patients with raised urea concentrations was almost double (11.5%). A raised admission serum urea concentration was an independent predictor for mortality at 30 days, 90 days, 1 year and 2 years. Mortality was significantly increased in patients admitted with: raised or low serum sodium, raised serum potassium and raised serum creatinine.
CONCLUSION: Mortality is high following hip fracture. Patients admitted with a raised serum urea are at increased risk of death at all time intervals analysed up to and including 2 years. This group of patients may require a separate care pathway that provides more intensive management of fluid and electrolyte balance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815394     DOI: 10.1016/j.injury.2006.04.121

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  24 in total

1.  Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

Authors:  Tatyana Vikulina; Xian Fan; Masayoshi Yamaguchi; Susanne Roser-Page; Majd Zayzafoon; David M Guidot; Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Clinical impact of indirect markers of renal function in elderly patients with hip fracture.

Authors:  Coral López-Martínez; Emanuel Tovar-Rivera; Ivonne K Becerra-Laparra; Norberto C Chávez-Tapia
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-09

3.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

Review 4.  HIV and bone metabolism.

Authors:  Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Discov Med       Date:  2011-05       Impact factor: 2.970

Review 5.  Bone Remodeling and the Microbiome.

Authors:  Roberto Pacifici
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 6.  Complications of hip fractures: A review.

Authors:  Pedro Carpintero; Jose Ramón Caeiro; Rocío Carpintero; Angela Morales; Samuel Silva; Manuel Mesa
Journal:  World J Orthop       Date:  2014-09-18

7.  Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery.

Authors:  Finnian R Mc Causland; John Wright; Sushrut S Waikar
Journal:  J Hosp Med       Date:  2014-02-13       Impact factor: 2.960

8.  Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency.

Authors:  Francesco Grassi; Abdul Malik Tyagi; John W Calvert; Laura Gambari; Lindsey D Walker; Mingcan Yu; Jerid Robinson; Jau-Yi Li; Gina Lisignoli; Chiara Vaccaro; Jonathan Adams; Roberto Pacifici
Journal:  J Bone Miner Res       Date:  2015-12-23       Impact factor: 6.741

9.  Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients.

Authors:  C M Madsen; C Jantzen; J B Lauritzen; B Abrahamsen; H L Jorgensen
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

10.  Which patients are at risk for kidney dysfunction after hip fracture surgery?

Authors:  George A Macheras; Konstantinos Kateros; Stefanos D Koutsostathis; Stamatios A Papadakis; Eleftherios Tsiridis
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.